Skip to content
★ Sign in to follow
JK

Jakob Knudsen

Board Director
Director
ExpreS2ion Biotech Holding ABExpreS2ion Biotech Holding AB (EXPRS2)
Insider activity · 24 months1 buy0 salesCumulative net flow
Total declarations
27
Companies
2
▲ Purchases (6 ops.)
€34k
▼ Sales (6 ops.)
€141k

Latest filing published 06 May 2026 for ExpreS2ion Biotech Holding AB, €13k.

Filing timeline

BuySale
Jakob Knudsen

Insider track record

Disclosed buys
6
Disclosed sells
6
Signal history

Closed purchases

Market purchases
6

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Jakob Knudsen: trading record in brief

Jakob Knudsen (board member) discloses dealings in 2 companies, chiefly ExpreS2ion Biotech Holding AB (EXPRS2) and ExpreS2ion Biotech Holding AB. Between 13 July 2020 and 6 May 2026, the trades on record add up to 27 filings.

Both buying and selling appear: 6 purchases worth €34k, against 6 sales worth €141k. No amount is published for 1 filing, which the totals therefore leave out. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 4 share grants. Since January 2026: 1 purchase and no sales on the market.

In size, the median ticket on the buying side is €3,063.

The record was last updated on 6 May 2026 with an open-market purchase (€13k) in ExpreS2ion Biotech Holding AB. Typically, a trade is published a median of 1 day after it takes place. For comparison, MAR article 19 gives managers three business days to notify a trade. This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.

Companies and markets linked to Jakob Knudsen

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations23 total

23 of 23 declarations